Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A

3(42.9%)

Phase 1

1(14.3%)

Phase 3

1(14.3%)

Phase 2

1(14.3%)

Phase 4

1(14.3%)

7Total

N/A(3)

Phase 1(1)

Phase 3(1)

Phase 2(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT06971952Not ApplicableRecruiting

Tuberculosis in Rural and Malnourished Populations

Role: collaborator

NCT06624137Recruiting

Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics

Role: collaborator

NCT04675398Not ApplicableActive Not Recruiting

Adaptive Deep Brain Stimulation to Improve Motor and Gait Functions in Parkinson's Disease

Role: collaborator

NCT07424508Not ApplicableEnrolling By Invitation

Movement State-dependent Adaptive DBS for PD

Role: collaborator

NCT03897946Phase 4Completed

Evaluating Immunogenicity of a Birth Dose of HBV Vaccine in the DRC

Role: collaborator

NCT00185731Phase 2Completed

Phase 2 Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma

Role: collaborator

NCT01175551Completed

Direct Measurements of Cervical Remodeling for Predicting Preterm Birth

Role: collaborator

NCT00209352Phase 3Completed

Long-Term Oral Acyclovir Usage to Prevent Herpes Zoster Virus Infection After Bone Marrow Transplant

Role: collaborator

NCT00247091Completed

Impact of HIV on Measles and Measles Immunisation

Role: collaborator

NCT00002141Phase 1Completed

A Phase I Trial to Evaluate the Safety and Pharmacokinetics of 1592U89

Role: lead

All 10 trials loaded